Learn more

CENTRE HOSPITALIER UNIV BORDEAUX

Overview
  • Total Patents
    27
  • GoodIP Patent Rank
    62,337
  • Filing trend
    ⇩ 72.0%
About

CENTRE HOSPITALIER UNIV BORDEAUX has a total of 27 patent applications. It decreased the IP activity by 72.0%. Its first patent ever was published in 2008. It filed its patents most often in Australia, Brazil and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, medical technology and measurement are NANJING DRUM TOWER HOSPITAL, UNIV OF PITTSBURGH—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION and AL KON RISERCH LTD.

Patent filings per year

Chart showing CENTRE HOSPITALIER UNIV BORDEAUXs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Dumas De La Roque Eric 5
#2 Cornelis François 5
#3 Cornelis Francois 3
#4 Thambo Jean-Benoit 2
#5 Diolez Philippe 2
#6 Cochet Hubert 2
#7 Frédéric Marin 2
#8 Taieb Alain 2
#9 Petitjean Olivier 2
#10 Leaute-Labreze Christine 2

Latest patents

Publication Filing date Title
AU2018265591A1 Method of segmentation of a three-dimensional image for generating a model of a myocardial wall for the detection of at least one singular zone of electrical circulation
BR112019012253A2 mmp9 inhibitors and their uses in the prevention or treatment of a depigmentation disorder
EP3525860A1 Mask for artificial ventilation of a patient
WO2018020150A1 Intraosseous stent
EP3300733A1 Substance selected among irinotecan, an irinotecan active metabolite, 5-fluoro-uracile, a pharmaceutical salt thereof and a mixture thereof, for use in the treatment of fibrosis
AU2016319184A1 Compounds for the treatment of diseases linked to mitochondrial reactive oxygen species (ROS) production
BR112018004518A2 compounds for the treatment of diseases linked to the production of reactive mitochondrial oxygen species (ros)
FR3050925A1 Intra-bone injection system for surgical cement
AU2015254675A1 Method for quantifying the presence of fats in a region of the heart
AU2014201660A1 Use of a beta blocker for the manufacture of a medicament for the treatment of hemangiomas